Further studies explicitly determined that IL-17 is involved in colorectal cancer cell proliferation [37], migration and invasion [38], angiogenesis [39], and enhanced drug resistance [40, 41] by regulating a series of downstream signaling pathways, significantly improving the tumorigenesis, invasive and distant metastasis capabilities of colorectal cancer. Here, IL17A is linked to colorectal cancer.